Team Konexio
-

Matix Fertilisers, promoted by Nishant Kanodia, wins ‘Best Production Performance Award 2025 for a Nitrogenous Fertiliser Plant’
New Delhi : Matix Fertilisers and Chemicals Limited, promoted by Nishant Kanodia, secured two significant recognitions at the 2025 Fertiliser Association of India (FAI) Annual Seminar. The company received awards for ‘Best Production Performance for a Nitrogenous…
-

Malaysia Airlines Ushers in a Season of Merry Moments with Global Year-End Sale
Exclusive fares for 2025 holidays and 2026 adventures invite Indian travellers to plan meaningful journeys ahead India : As the festive season approaches and travellers across Malaysia and beyond prepare for long-awaited reunions, Malaysia Airlines…
-

16X y-o-y growth in orders in H2 2025 and over 53 million unique visitors: Flipkart Minutes showcases tremendous growth with deepened reach into 30+ new cities
Bengaluru : Flipkart’s quick commerce offering, Flipkart Minutes, concluded 2025 with an unprecedented performance, fueled by growing customer loyalty, rampant geographic expansion, and deeper engagement across high-demand categories. The platform has recorded 16X growth in orders in H2…
-

Quest Global joins the United Nations Global Compact initiative
Bengaluru, India : Quest Global, the world’s largest independent pure-play engineering services company, is pleased to announce that it has joined the United Nations Global Compact initiative, a voluntary initiative for the development, implementation and…
-

JSW Paints completes the acquisition process of Akzo Nobel India
Mumbai : JSW Paints Limited (“JSW Paints”) today acquired a majority stake of 60.76% in Akzo Nobel India Limited (“ANIL”) from Akzo Nobel N.V. and its affiliates. JSW Paints had already acquired 0.44% stake from…
-

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension
Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3% (5…





